Cleared Traditional

K220924 - Elecsys HSV-2 IgG (08948887160) (FDA 510(k) Clearance)

Oct 2022
Decision
195d
Days
Class 2
Risk

K220924 is an FDA 510(k) clearance for the Elecsys HSV-2 IgG (08948887160). This device is classified as a Enzyme Linked Immunosorbent Assay, Herpes Simplex Virus, Hsv-2 (Class II - Special Controls, product code MYF).

Submitted by Roche Diagnostics (Indianapolis, US). The FDA issued a Cleared decision on October 12, 2022, 195 days after receiving the submission on March 31, 2022.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3305.

Submission Details

510(k) Number K220924 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 31, 2022
Decision Date October 12, 2022
Days to Decision 195 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF

Device Classification

Product Code MYF — Enzyme Linked Immunosorbent Assay, Herpes Simplex Virus, Hsv-2
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.3305